Cumulative systolic BP and changes in urine albuminto-creatinine ratios in nondiabetic participants of the multi-ethnic study of atherosclerosis

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 11, 2015, Pages 1922-1929

  Zemaitis, Paul ^a   Liu, Kiang ^b   Jacobs, David R ^c,d   Cushman, Mary ^e   Durazo Arvizu, Ramon ^a   Shoham, David ^a   Palmas, Walter ^f   Cooper, Richard ^a   Kramer, Holly ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f Department of Pathology University of Vermont ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CUMULATIVE SYSTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RENAL SYSTEM PARAMETERS; SYSTOLIC BLOOD PRESSURE; URINE ALBUMIN TO CREATININE RATIO; ALBUMINURIA; BLOOD PRESSURE; DIABETES MELLITUS; DISEASE COURSE; PATHOPHYSIOLOGY; RISK FACTOR; SYSTOLE; URINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALBUMINURIA; ATHEROSCLEROSIS; BIOMARKERS; BLOOD PRESSURE; CREATININE; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SYSTOLE;

EID: 84923930493     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02450314     Document Type: Article

References (28)

1. Bianchi S, Bigazzi R, Campese VM: Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications. Am J Kidney Dis 34: 973–995, 1999.
2. Lowenstein J, Beranbaum ER, Chasis H, Baldwin DS: Intrarenal pressure and exaggerated natriuresis in essential hypertension. Clin Sci 38: 359–374, 1970.
3. West JN, Gosling P, Dimmitt SB, Littler WA: Non-diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure. Clin Sci (Lond) 81: 373–377, 1991.
4. Knight EL, Kramer HM, Curhan GC: High-normal blood pressure and microalbuminuria. Am J Kidney Dis 41: 588–595, 2003.
5. Martınez MA, Moreno A, Aguirre de Carcer A, Cabrera R, Rocha R, Torre A, Nevado A, Ramos T, Neri J, Anton G, Miranda I, Fernandez P, Rodrıguez E, Miquel A, Martınez JL, Rodrıguez M, Eisman C, Puig JG; MAPA—Madrid Working Group: Frequency and determinants of microalbuminuria in mild hypertension: A primary-care-based study. J Hypertens 19: 319–326, 2001.
6. Redon J, Rovira E, Miralles A, Julve R, Pascual JM: Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension. Hypertension 39: 794–798, 2002.
7. Gerstein HC, Mann JF, Pogue J, Dinneen SF, Halle JP, Hoogwerf B, Joyce C, Rashkow A, Young J, Zinman B, Yusuf S; TheHOPE Study Investigators: Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. Diabetes Care 23[Suppl 2]: B35–B39, 2000.
8. Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D: Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96: 308–315, 1997.
9. U.K. Prospective Diabetes Study Group: U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: A progressive disease. Diabetes 44: 1249–1258, 1995.
10. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med 329: 977–986, 1993.
11. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O’Leary D, Saad MF, Shea S, Szklo M, Tracy RP: Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156: 871–881, 2002.
12. Jacobs DR Jr, Murtaugh MA, Steffes M, Yu X, Roseman J, Goetz FC: Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: The Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 155: 1114–1119, 2002.
13. Mattix HJ, Hsu CY, Shaykevich S, Curhan G: Use of the albumin/ creatinine ratio to detect microalbuminuria: Implications of sex and race. J Am Soc Nephrol 13: 1034–1039, 2002.
14. Kramer H, Jacobs DR Jr, Bild D, Post W, Saad MF, Detrano R, Tracy R, Cooper R, Liu K; The Multi-Ethnic Study of Atherosclerosis: Urine albumin excretion and subclinical cardiovascular disease. Hypertension 46: 38–43, 2005.
15. Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 7: 930–937, 1996.
16. Zheng Y, Schneck M, Jacobs DR, Liu K, Allison MA, O’Leary D, Durazo-Arvizu R, Darwin C, Kramer H: Association of carotid intima media thickness (CIMT) with progression of urine albumin/creatinine ratios in the Multi-Ethnic Study of Atherosclerosis. Am J Kidney Dis 57: 62–70, 2011.
17. Wachtell K, Olsen MH, Dahlof B, Devereux RB, Kjeldsen SE, Nieminen MS, Okin PM, Papademetriou V, Mogensen CE, Borch- Johnsen K, Ibsen H: Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens 20: 405–412, 2002.
18. Lieb W, Xanthakis V, Sullivan LM, Aragam J, Pencina MJ, Larson MG, Benjamin EJ, Vasan RS: Longitudinal tracking of left ventricular mass over the adult life course: Clinical correlates of short- and long-term change in the framingham offspring study. Circulation 119: 3085–3092, 2009.
19. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S; HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421–426, 2001.
20. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative metaanalysis. Lancet 375: 2073–2081, 2010.
21. Schmieder RE, Mann JF, Schumacher H, Gao P, Mancia G, Weber MA, McQueen M, Koon T, Yusuf S; ONTARGET Investigators: Changes in albuminuria predict mortality and morbidity in patients with vascular disease. J Am Soc Nephrol 22: 1353–1364, 2011.
22. Cushman WC, Evans GW, Byington RP, Goff DC Jr, GrimmRH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F; ACCORD Study Group: Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362: 1575–1585, 2010.
23. Mancia G: Effects of intensive blood pressure control in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation 122: 847–849, 2010.
24. ClinicalTrials.gov. Systolic blood pressure intervention trial (SPRINT). clinical (ClinicalTrials.gov identifier: NCT01206062) Available at: http://clinicaltrials.gov/ct2/show/NCT01206062. Accessed May 1, 2013.
25. Smulders YM, Slaats EH, Rakic M, Smulders FT, Stehouwer CD, Silberbusch J: Short-term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus. J Lab Clin Med 132: 39–46, 1998.
26. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1–12, 2003.
27. Agewall S, Wikstrand J, Ljungman S, Fagerberg B: Urinary albumin excretion is associated with the intima-media thickness of the carotid artery in hypertensive males with noninsulin- dependentdiabetes mellitus. J Hypertens 13: 463–469, 1995.
28. James PA, Oparil S, Carter BL, Cushman WC, Dennison- Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E: 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311: 507–520, 2014.